Sebacia Postmarket Study of Real-World Use



Status:Recruiting
Conditions:Acne, Acne, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:12 - 45
Updated:1/30/2019
Start Date:January 1, 2019
End Date:June 2020
Contact:VP, Clinical & Regulatory Affairs
Email:gretchen@sebacia.com
Phone:770-688-1280

Use our guide to learn which trials are right for you!

A Prospective, Multicenter, Postmarket Study of Sebacia Microparticles Treatment in Patients Using Topical Acne Products for Mild to Moderate Inflammatory Acne Vulgaris

Postmarket study of Sebacia Microparticles treatment during adoption into clinical use for
patients with mild to moderate inflammatory acne vulgaris.


Inclusion Criteria:

- Mild to moderate facial inflammatory acne vulgaris (IGA 2 or 3)

- Between 10 and 50 papules/pustules

- Fitzpatrick skin phototype I, II or III

- Able to provide informed consent and comply with study schedule and other requirements

Exclusion Criteria:

- Moderately severe or severe acne vulgaris (IGA 4 or 5)

- Nodulocystic acne, significant scarring or excoriation

- Requires oral retinoid, antibiotic or corticosteroid for acne

- New or fluctuating hormone or hormone-regulating therapy

- Photosensitivity or allergy to gold

- Medical or mental health condition that would pose a risk to patient or impair
treatment and evaluation
We found this trial at
6
sites
Miami, Florida 33173
Phone: 305-279-6060
?
mi
from
Miami, FL
Click here to add this to my saved trials
Austin, Texas 78705
Phone: 512-454-3781
?
mi
from
Austin, TX
Click here to add this to my saved trials
Boston, Massachusetts 02116
?
mi
from
Boston, MA
Click here to add this to my saved trials
Murfreesboro, Tennessee 37130
Phone: 615-410-3460
?
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
Pflugerville, Texas 78660
Phone: 512-279-2545
?
mi
from
Pflugerville, TX
Click here to add this to my saved trials
Spokane, Washington 99204
Phone: 509-343-3710
?
mi
from
Spokane, WA
Click here to add this to my saved trials